Correlation Between Adaptive Biotechnologies and Vir Biotechnology

Can any of the company-specific risk be diversified away by investing in both Adaptive Biotechnologies and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptive Biotechnologies and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adaptive Biotechnologies Corp and Vir Biotechnology, you can compare the effects of market volatilities on Adaptive Biotechnologies and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptive Biotechnologies with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptive Biotechnologies and Vir Biotechnology.

Diversification Opportunities for Adaptive Biotechnologies and Vir Biotechnology

0.36

Correlation Coefficient

Adaptive Biotechnologies  Vir Biotechnology

Weak diversification

The 3 months correlation between Adaptive and Vir is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Adaptive Biotechnologies Corp and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Adaptive Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptive Biotechnologies Corp are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Adaptive Biotechnologies i.e., Adaptive Biotechnologies and Vir Biotechnology go up and down completely randomly.

Pair Corralation between Adaptive Biotechnologies and Vir Biotechnology

Given the investment horizon of 90 days Adaptive Biotechnologies Corp is expected to generate 0.93 times more return on investment than Vir Biotechnology. However, Adaptive Biotechnologies Corp is 1.07 times less risky than Vir Biotechnology. It trades about 0.17 of its potential returns per unit of risk. Vir Biotechnology is currently generating about 0.01 per unit of risk. If you would invest  558.00  in Adaptive Biotechnologies Corp on September 26, 2024 and sell it today you would earn a total of  81.00  from holding Adaptive Biotechnologies Corp or generate 14.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Adaptive Biotechnologies Corp  vs.  Vir Biotechnology

Adaptive Biotechnologies

Risk-Adjusted Performance

8 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Adaptive Biotechnologies Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Adaptive Biotechnologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

Vir Biotechnology

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Vir Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady forward indicators, Vir Biotechnology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Adaptive Biotechnologies and Vir Biotechnology

The main advantage of trading using opposite Adaptive Biotechnologies and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptive Biotechnologies position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.

The idea behind Adaptive Biotechnologies Corp and Vir Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.